Denali Therapeutics (DNLI) Stock Price, News, Quotes-Moomoo

US Stock MarketDetailed Quotes

DNLI Denali Therapeutics

Watchlist

20.610
-0.710-3.33%

Close Dec 27 16:00 ET

20.610
0.0000.00%

Post 16:20 ET

2.97BMarket Cap-7.47P/E (TTM)

Full Hours

5D
Daily
Weekly
Monthly
1Q
1Y

Trade Overview

Unit: --

Capital Trend

IntradayDayWeekMonth

No Data

News

Insiders At Denali Therapeutics Sold US$1.8m In Stock, Alluding To Potential Weakness
Simply Wall StDec 23 08:31 ET
Denali Therapeutics Upgraded to Buy From Hold at Stifel
Yahoo FinanceDec 17 06:25 ET
Stifel Upgrades Denali Therapeutics(DNLI.US) to Buy Rating, Raises Target Price to $37
Moomoo NewsDec 16 07:31 ET · Ratings
Stifel Upgrades Denali Therapeutics to Buy, Announces $37 Price Target
BenzingaDec 16 06:58 ET · Ratings
Denali Therapeutics Shares Are Trading Higher. The Stock May Be Moving on Continued Strength After Announcing on Thursday It Began Its Phase 2a Study of LRRK2 Inhibitor BIIB122 for LRRK2-associated Parkinson's Disease With Its First Participant Dosed.
BenzingaDec 6 13:03 ET
Why Is Denali Therapeutics (DNLI) Down 21.2% Since Last Earnings Report?
Yahoo FinanceDec 6 11:31 ET

Comments

Meltyy

May 16 01:14

🔔 Baker Bros. Q1 ‘24* Holdings Released... 🐳

» Holdings: 87
» Holdings in Top 20: 86.71%
» Qtr over Qtr Change**: -9.29%
Top Holdings:
$Incyte (INCY.US)$
$BeiGene (BGNE.US)$
$ACADIA Pharmaceuticals (ACAD.US)$
$Madrigal Pharmaceuticals (MDGL.US)$
$Rhythm Pharmaceuticals (RYTM.US)$
$Revolution Medicines (RVMD.US)$
$Kymera Therapeutics (KYMR.US)$
$AbCellera Biologics (ABCL.US)$
$Bicycle Therapeutics (BCYC.US)$
$Edgewise Therapeutics (EWTX.US)$
$Immunocore (IMCR.US)$
$Kodiak Sciences (KOD.US)$
$Roivant Sciences (ROIV.US)$
...

Kevin Travers

Feb 27 10:02

Columns Biotechnology Stocks Climbing on Earnings and Test Results: What to Watch

$Viking Therapeutics (VKTX.US)$skyrocketed 77% after positive drug trial news Tuesday, leading to what proved to be a strong morning for pharmaceutical stocks.
Here are some top stocks in the sector climbing on drug trial and earnings news:
$Janux Therapeutics (JANX.US)$shares shot up 205% to $36.00 after the company announced updated clinical data for both of its clinical programs, reaching over $1.50B in market cap.
$Ligand Pharmaceuticals (LGND.US)$gained 23%...

Moomoo AI

Feb 7 06:59

Denali Therapeutics' continuous stock price drop questions the initial investment decision. The company's struggle to increase revenue while unprofitable worries investors. Despite a recent 3.9% rise, the company's disappointing performance over the past years resulted in a yearly 3% total loss for shareholders over five years.